… The pathogenesis of multiple sclerosis remains a dilemma despite many years of study. Evi…
On the other hand, the well-documented facts that multiple sclerosis plaques are invariably …

… Multiple sclerosis (MS) is a chronic inflammatory demyelinating and neurodegenerative …
Here, we review the current understanding of the molecular effects of vitamin D beyond calcium …

This review discusses type I interferon (IFN) immunogenicity with focus on methods of detection
of anti-IFN antibodies in patients treated with human recombinant IFN-β. Pitfalls involved …

… Multiple sclerosis (MS) is the most common acquired … ► It is hypothesized that multiple
sclerosis (MS) is a multifactorial … This article critically discusses the potential interplay of …

Multiple sclerosis (MS) is characterized by demyelination and axonal loss that results in
progressive disability. Recent advances in understanding the immune pathogenesis of MS …

… disorders in laboratory animals that is used to model multiple sclerosis (MS). However, few
agents … The use of EAE is critically appraised with the aim of provoking thought, improving …

… This review summarizes Phase III clinical trial data available for fingolimod. The main … the
first oral compound available for treatment of multiple sclerosis (MS) and just recently approved …

… are available for treatment of multiple sclerosis (MS). Interferons… This article aimed to review
all the clinical trials on immune-… Aim of this review is to give a critical reading of the published …

… Citation12 In a phase IIb study, 257 patients with multiple sclerosis were enrolled to receive
three different doses of BG-12 or placebo. Citation13 Compared with placebo, BG-12 at 240 …

… to further our understanding of the role of cannabinoids in multiple sclerosis treatment. … well
as the research priorities ahead, a critical analysis of the literature is presented in this review. …